Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study

Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study

ABSTRACT Background The current standard treatment for advanced and metastatic esophageal squamous cell carcinoma (ESCC) involves a combination of immunotherapy and chemotherapy, but paclitaxel's hormone preconditioning can reduce immune response and effectiveness. Polymeric micellar paclitaxel...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaoyou Li, Jiamin Shi, Jinghua Zhu, Jingni Zhu, Fei Yan, Delin Liu, Guochun Cao
Format:	Article
Language:	English
Published:	Wiley 2025-04-01
Series:	Thoracic Cancer
Subjects:	chemotherapy esophageal squamous cell carcinoma immunology polymeric micellar paclitaxel tislelizumab
Online Access:	https://doi.org/10.1111/1759-7714.70055
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
by: A. G. Kedrova, et al.
Published: (2019-11-01)

Matching-adjusted indirect comparison of tislelizumab plus lenvatinib versus sintilimab plus bevacizumab biosimilar as first-line treatment for unresectable hepatocellular carcinoma
by: Kunyuan Wang, et al.
Published: (2025-06-01)

PENURUNAN NILAI HANTARAN TULANG PADA PENDERITA KARSINOMA NASOFARING DENGAN KEMOTERAPI BERBASIS PLATINUM: KOMBINASI NEOADJUVANT PACLITAXEL-CISPLATIN DAN PACLITAXEL-CARBOPLATIN
by: Cika Apriliana, et al.
Published: (2019-02-01)

Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
by: Shao-Jing Wang, et al.
Published: (2025-03-01)

Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial
by: Xiao Yang, et al.
Published: (2025-08-01)

PROPERTIES OF MICELLAR CASEIN AND APPLICATION IN FOOD INDUSTRY
by: N. A. Dzhangiryan, et al.
Published: (2023-05-01)

A pathological complete response to capecitabine plus oxaliplatin regimen combined with tislelizumab in advanced gastric cancer with liver metastases: A case report
by: Li-Ping Sheng, et al.
Published: (2024-12-01)

Efficacy and safety of nanoparticle albumin-bound paclitaxel plus cisplatin or nedaplatin plus tegafur/gimeracil/oteracil as induction chemotherapy regimen for hypopharyngeal cancer
by: Cailing Jiang, et al.
Published: (2025-02-01)

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study
by: Qi Zhao, et al.
Published: (2025-08-01)

Development of a premix based on micellar casein for fortification of meat systems with vitamin A
by: N. A. Dzhangiryan, et al.
Published: (2024-04-01)

Tislelizumab-induced anaphylactic shock: a case report
by: Haiyu Niu, et al.
Published: (2025-07-01)

Clinical Pharmacology Overview of Tislelizumab in Patients With Advanced Tumors With a Focus on Racial Impact
by: Tian Yu, et al.
Published: (2025-05-01)

Use of Mixed Micelles in Micellar Electrokinetic Chromatography Method for Determination of Dexamethasone, Prednisolone and Triamcinolone in Pharmaceutical Formulations
by: Karen A. Escamilla-Lara, et al.
Published: (2025-06-01)

Stability indicating green micellar liquid chromatographic method for simultaneous analysis of Metformin and dapagliflozin in their tablets
by: Aya A. Marie, et al.
Published: (2025-06-01)

A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancerResearch in context
by: Qiang Wen, et al.
Published: (2025-07-01)

Efficacy of albumin-bound paclitaxel versus paclitaxel in esophageal cancer: a systematic review and meta-analysis
by: Jiayang Song, et al.
Published: (2025-08-01)

Cost-effectiveness analysis of tislelizumab plus chemotherapy as first-line treatment for HER2-negative advanced gastric or gastro-oesophageal junction adenocarcinoma
by: Liangliang Zou, et al.
Published: (2025-05-01)

Post-marketing safety concerns with Tislelizumab: a disproportionality analysis of the FDA adverse event reporting system
by: Chen Li, et al.
Published: (2025-05-01)

Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou–Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells
by: Jana Ismail, et al.
Published: (2025-02-01)

Efficacy and safety of Tislelizumab combined with Axitinib as first-line treatment for intermediate- and high-risk metastatic clear-cell renal cell carcinoma
by: Jie Cui, et al.
Published: (2025-05-01)

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for extensive-stage small cell lung cancer from the perspective of the healthcare system in China
by: Feng Chen, et al.
Published: (2025-05-01)

PERBANDINGAN KEJADIAN LEUKOPENIA DAN TROMBOSITOPENIA PADA PENDERTIA KARSINOMA NASOFARING YANG MENDAPATKAN KEMOTERAPI PACLITAXEL CISPLATIN DAN CISPLATIN 5-FLUOROURACIL (5-FU)
by: Nadya Tara Audina, et al.
Published: (2019-10-01)

Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial
by: Ke Zhang, et al.
Published: (2025-02-01)

Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings
by: Lufan Xu, et al.
Published: (2025-03-01)

Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022-06-01)

Hyperfractionated radiotherapy with concurrent weekly paclitaxel and carboplatin for locally advanced unresectable head and neck squamous cell carcinoma
by: Perumal S, et al.
Published: (2025-06-01)

Comparative acute toxicity of intravenous paclitaxel and sirolimus in rats
by: Jing Xie, et al.
Published: (2025-01-01)

Solidified reverse micellar solution-based chitosan-coated solid lipid nanoparticles as a new approach to enhance oral delivery of artemether in malaria treatment
by: Franklin Chimaobi Kenechukwu, et al.
Published: (2025-03-01)

Tislelizumab and GP regimen neoadjuvant therapy followed by concurrent chemoradiotherapy with nimotuzumab in patients with stage IVA nasopharyngeal carcinoma: a retrospective study
by: Mingfen Lai, et al.
Published: (2025-06-01)

Tislelizumab-induced type 1 diabetic ketoacidosis in a patient with small cell lung cancer: a case report
by: Jie Zhu, et al.
Published: (2025-03-01)

New Insights into Common Bean (<i>Phaseolus vulgaris</i> L.) Sprouts: Pilot Studies on the Formulation of a Cosmeceutical Based on Micellar Extracts Bean Sprouts
by: Katarzyna Wojciechowska, et al.
Published: (2025-02-01)

Corrigendum: Case report: Multi-organ injuries induced by tislelizumab
by: Man Yuan, et al.
Published: (2025-06-01)

Case Report: Immune-mediated acute liver failure induced by tislelizumab in a patient with advanced cervical cancer
by: Chaoxia Liu, et al.
Published: (2025-08-01)

Pulmonary artery pseudoaneurysm-induced massive hemoptysis after chemotherapy combined with tislelizumab for lung squamous cell carcinoma: a case report
by: Xue-Jiao Yang, et al.
Published: (2025-04-01)

Paclitaxel resistance in breast cancer: Current challenges and recent advanced therapeutic strategies
by: Heidi A. Abouzeid, et al.
Published: (2025-01-01)

Circular RNAs: key regulators of paclitaxel sensitivity and resistance in cancer
by: Zahra Tajik, et al.
Published: (2025-08-01)

Camrelizumab, an Anti‐PD‐1 Monoclonal Antibody, Plus Carboplatin and Nab‐Paclitaxel as First‐Line Setting for Extensive‐Stage Small‐Cell Lung Cancer: A Phase 2 Trial and Biomarker Analysis
by: Jia Yu, et al.
Published: (2025-08-01)

Cost-effectiveness analysis of penpulimab plus carboplatin-paclitaxel as first-line treatment for metastatic squamous non-small-cell lung cancer in China
by: Luwei Wang, et al.
Published: (2025-07-01)

Emerging trends and global collaboration in Paclitaxel resistance research for breast cancer: a comprehensive bibliometric study
by: Yuxuan Meng, et al.
Published: (2025-08-01)

A novel isoquinoline mitophagy inducer ameliorates paclitaxel-induced peripheral neuropathy in Drosophila and mouse models
by: Sangwoo Im, et al.
Published: (2025-07-01)